Comparison of the effects of Chlordiazepoxide and Cranial Electrotherapy Stimulation in preventing the changes of potassium due to surgical anxiety.

Comparison of Chlordiazepoxide and Cranial Electrotherapy Stimulation Effects On Potassium Changes Caused by Preoperative Anxiety in Patients Undergoing Anesthesia Class 1 Surgery

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190307042954N1

Enrollment

100

Registered

2019-06-25

Start date

2019-07-06

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Anxiety. Factors influencing health status and contact with health services

Interventions

Intervention 1: Intervention group: The first intervention group in this group is given to patients with 5 mg of chlordiazepoxide orally, an Hakim pharmacy, with an appointment with anesthesiologist a

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients Undergoing Anesthesia Class 1 Surgery Hospitalization at least one day before surgery Lack of recognized psychiatric and neurological disorders Non - abuse of drugs or the use of any effective medication on the nervous system The lack of diseases that cause anxiety about the symptoms, such as hyperthyroidism and pheochromocytoma Not having opiate addiction Persian language dominance Age 18-60 years old Do not use drugs that affect sodium and potassium

Exclusion criteria

Exclusion criteria: Patients undergoing surgery for a second or more time Patients who were received 48 hours prior to the operation of FFP or any blood products The presence of any precautionary measures for electrical stimulation including the presence of metal body in the head and neck or heart pacemaker and a history of headache

Design outcomes

Primary

Measure	Time frame
Anxiety Score in the Amsterdam Questionnaire. Timepoint: Measurement of anxiety in the beginning of the study (before the intervention) and 2 hours after the intervention. Method of measurement: Anxiety Index questionnaire and the need for information before the practice of Amsterdam.;The amount of potassium in the blood. Timepoint: Measurement of blood potassium levels at the beginning of the study (before the intervention) and 2 hours after the intervention. Method of measurement: The samples will be analyzed by an analyzer electrolyte analyzer (XD-683) manufactured in China and an Eldor Efferometer device manufactured in Germany.	—

Measure

Time frame

Anxiety Score in the Amsterdam Questionnaire. Timepoint: Measurement of anxiety in the beginning of the study (before the intervention) and 2 hours after the intervention. Method of measurement: Anxiety Index questionnaire and the need for information before the practice of Amsterdam.;The amount of potassium in the blood. Timepoint: Measurement of blood potassium levels at the beginning of the study (before the intervention) and 2 hours after the intervention. Method of measurement: The samples will be analyzed by an analyzer electrolyte analyzer (XD-683) manufactured in China and an Eldor Efferometer device manufactured in Germany.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTayebeh Arabzadeh

Yazd University of Medical Sciences

T.arabzadeh@ssu.ac.ir+98 35 3623 4112

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026